Integrative Genomics Analyses Reveal Molecularly Distinct Subgroups of B-Cell Chronic Lymphocytic Leukemia Patients with 13q14 Deletion-Reference-Cited by-同舟云学术

Integrative Genomics Analyses Reveal Molecularly Distinct Subgroups of B-Cell Chronic Lymphocytic Leukemia Patients with 13q14 Deletion

Published:2010-10-14 Issue:23 Volume:16 Page:5641-5653
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Mosca Laura,Fabris Sonia,Lionetti Marta,Todoerti Katia,Agnelli Luca,Morabito Fortunato,Cutrona Giovanna,Andronache Adrian,Matis Serena,Ferrari Francesco,Gentile Massimo,Spriano Mauro,Callea Vincenzo,Festini Gianluca,Molica Stefano,Deliliers Giorgio Lambertenghi,Bicciato Silvio,Ferrarini Manlio,Neri Antonino

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genes selection using deep learning and explainable artificial intelligence for chronic lymphocytic leukemia predicting the need and time to therapy;Frontiers in Oncology;2023-08-31

2. Super-Enhancer–Associated nine-gene prognostic score model for prediction of survival in chronic lymphocytic leukemia patients;Frontiers in Genetics;2022-09-15

3. Structure and prognostic signifi cance of 13q14 deletion in chronic lymphocytic leukemia;Russian journal of hematology and transfusiology;2022-04-11

4. Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia;Frontiers in Oncology;2021-08-02

5. Which prognostic marker is responsible for the clinical heterogeneity in CLL with 13q deletion?;Molecular Cytogenetics;2021-01-06